PLI Scheme: For Drug Intermediates and APIs

PLI Scheme:

Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs).

Indian pharmaceutical industry:

  • It is the 3rd largest in the world by volume.
  • It has high market presence in several advanced economies such as the US and EU. The industry is well known for its production of affordable medicines, particularly in the generics space.
  • However the country is significantly dependent on the import of basic raw materials, viz., Bulk Drugs that are used to produce medicines.

About the PLI scheme:

  • To make India a manufacturing hub, the government had initially announced the PLI scheme for mobile phones, pharma products, and medical equipment sectors.
  • Notified on April 1, 2020, as a part of the National Policy on Electronics.
  • It proposes a financial incentive to boost domestic manufacturing and attract large investments in the electronics value chain.
  • In November 2020, the Union Cabinet gave its approval to introduce the Production-Linked Incentive (PLI) Scheme in 10 more sectors for enhancing India’s manufacturing capabilities and exports (Atmanirbhar Bharat).

Need Monthly Current Affairs PDF?

Get everything on your phone with our all in one app for your UPSC Preparation.

  • Get daily current affairs on you phone
  • Download monthly current affairs PDF
  • All India daily mock tests with ranking

DOWNLOAD the App on Play Store

Leave a Reply

Your email address will not be published. Required fields are marked *